Some key published and presented research findings include: Adoptive T cell receptor (TCR ... a second CAR molecule improved tumor specificity and enhanced NK cell activity Adding CD28 costimulation ...

Virologist Beata Halassy says self-treatment worked and was a positive experience — but researchers warn that it is not ...

Members of Medigene management as expert speakers, Prof. Dolores Schendel, Chief Scientific Officer and Kirsty Crame, MD, Vice President, Clinical Strategy & Development Presentations and seminars ...

Researchers say study offers proof-of-concept that targeting how T cells interact with metabolites in their environment can ...

The in vivo cell therapy seed Carisma Therapeutics planted with Moderna in 2022 is starting to sprout. | The in vivo cell ...

As cancer cells grow, they pump out metabolic byproducts such as lactic acid into the tumor microenvironment. Exhausted T ...

CAR-T cell therapy, a marvel of bioengineering, takes a patient’s own immune cells and reprograms them to attack cells ...